Pulmonology Xagena

Xagena Mappa
Xagena Newsletter
Medical Meeting

Search results for "Long-acting anticholinergic bronchodilator"

In patients with symptomatic asthma receiving ICS or ICS+LABA, phase III studies have demonstrated improved lung function with Tiotropium ( Spiriva ) Respimat, a once-daily long-acting anticholinergic ...

Once-daily Tiotropium ( Spiriva ) Respimat, a long-acting anticholinergic bronchodilator, has been shown in a phase III program to improve lung function and reduce severe exacerbation risk in severe a ...

Chronic obstructive pulmonary disease ( COPD ) is frequently accompanied by multimorbidities in affected patients. Even though the majority of these comorbidities are also related to advanced age and ...